The objective of this groundbreaking medication is to aid individuals who, due to congenital factors, have fewer than a full ...

Researchers from the Japanese startup Toregem Biopharma are planning to enroll patients who were born missing some or all of their teeth from birth, a condition called congenital anodontia ...